Breaking News, Promotions & Moves

Rentschler Biopharma Appoints Kassim Kolia as VP, Business Development

Also provides an update on the progress made at the ATMP facility since it was established last year.

Author Image

By: Charlie Sternberg

Associate Editor

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO), has hired Kassim Kolia as Vice President, Business Development to drive new client growth for the ATMP site in Stevenage, UK.   Kolia brings extensive biopharmaceutical manufacturing and business development experience, including ten years in the cell and gene therapy space. Kolia most recently headed Business Development at FinVector & Oy, where he was responsible for leading strategic business deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters